Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

1182.99.32 Boehringer Ingelheim Investigational Site, Beverly Hills

1182.99.31 Boehringer Ingelheim Investigational Site, Fort Lauderdale

1182.99.12 Boehringer Ingelheim Investigational Site, Providence

1182.99.1 Boehringer Ingelheim Investigational Site, Austin

1182.99.4 Boehringer Ingelheim Investigational Site, Houston

1182.99.54001, Capital Federal

1182.99.55002 Hospital DIA, Sacomã - São Paulo

1182.99.55004 Unidade de Referência em doenças Infecciosas Preveníveis, Santo André

1182.99.55001 Universidade Federal de Sao Paulo, São Paulo

1182.99.55003 Centro de Referência e Treinamento - DST/AIDS, Vila Mariana - Sao Paulo

1182.99.3301A Boehringer Ingelheim Investigational Site, Garches

1182.99.3306G Boehringer Ingelheim Investigational Site, Nantes

1182.99.3306K Boehringer Ingelheim Investigational Site, Nantes

1182.99.3310C Boehringer Ingelheim Investigational Site, Nice

1182.99.3310D Boehringer Ingelheim Investigational Site, Nice

1182.99.3310E Boehringer Ingelheim Investigational Site, Nice

1182.99.3310F Boehringer Ingelheim Investigational Site, Nice

1182.99.3310G Boehringer Ingelheim Investigational Site, Nice

1182.99.3310H Boehringer Ingelheim Investigational Site, Nice

1182.99.3304A Boehringer Ingelheim Investigational Site, Paris

1182.99.3304C Boehringer Ingelheim Investigational Site, Paris

1182.99.3302A Boehringer Ingelheim Investigational Site, Perpignan

1182.99.4909 Boehringer Ingelheim Investigational Site, Düsseldorf

1182.99.3912 Boehringer Ingelheim Investigational Site, Ancona

1182.99.3901 Boehringer Ingelheim Investigational Site, Milan

1182.99.3911 Boehringer Ingelheim Investigational Site, Milan

1182.99.3916 Boehringer Ingelheim Investigational Site, Milan

1182.99.3906 Boehringer Ingelheim Investigational Site, Pavia

1182.99.3402, Barcelona

1182.99.3407, Madrid